Iron(Iii)-Isomaltoside Injection Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 100mg/ml
Reference Brands: Monofer,, Diafer, Monoferric
Category: Anemia
Used in treating iron-deficiency anemia, Iron(III)-Isomaltoside (100 mg/mL) allows large single-dose infusions. Available as Monofer and Monoferric in EU/US markets. Ideal for pharma B2B supply. Iron(III)-Isomaltoside Injection is available in Injection and strengths such as 100mg/ml. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Iron(III)-Isomaltoside Injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Iron(III)-Isomaltoside Injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Iron(III)-Isomaltoside is a modern intravenous iron formulation used to treat iron-deficiency anemia in patients who cannot tolerate or respond to oral iron. Marketed under brand names like Monofer (EU) and Monoferric (US), it offers high-dose, once-per-week administration (up to 1,000 mg or more) with reduced risk of free iron toxicity. Available in 100 mg/mL concentration in vials of 1 mL to 10 mL, suitable for IV bolus or infusion. Manufactured under GMP-certified facilities, Iron(III)-Isomaltoside is ideal for hospitals, dialysis centers, and B2B global distribution. Contact us for bulk supply and regulatory support.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Iron(III)-Isomaltoside, also known as ferric derisomaltose, is used for the treatment of iron-deficiency anaemia in patients who cannot tolerate or do not respond to oral iron. It helps restore depleted iron stores in the body.
It is made from a complex of trivalent iron (ferric iron) bound to an isomaltoside carbohydrate, forming a stable iron–carbohydrate complex.
Its commonly known trade name is Monofer in many markets.
It is manufactured by Pharmacosmos.
The generic name is Iron(III)-Isomaltoside, also known as ferric derisomaltose.
The brand name is Monofer.
It is primarily manufactured in Denmark by Pharmacosmos.
Related Products
Epoetin Alfa
Strength:
1,000 IU, 2,000 IU, 4,000 IU, 10,000 IU, 40,000 IU
Form: injection (prefilled syringe)
Reference Brands: EPOGEN (USA), PROCRIT (USA)
View Details
Ferumoxytol Injection
Strength:
30 mg/mL
Form: Injection
Reference Brands: Feraheme (USA)
View Details
Deferoxamine
Strength:
500 mg/vial, 2 g/vial
Form: Lyophilized powder for injection
Reference Brands: Desferal
View Details
Deferasirox
Strength:
125 mg, 250 mg, 500 mg
Form: Tablets for Oral Suspension
Reference Brands: Exjade, Jadenu (film-coated)
View DetailsQuick Response Guaranteed | Verified Suppliers
